文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

外科重症监护中的铁调素与贫血:一项前瞻性队列研究

Hepcidin and Anemia in Surgical Critical Care: A Prospective Cohort Study.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论外科ICU贫血患者入ICU时血清铁调素显著升高,住院28天内逐渐下降,铁调素下降与网织红细胞反应增加和炎症反应减轻相关,但与贫血缓解无关。

本研究为前瞻性单中心非干预性临床研究,纳入100例外科成人ICU患者,在入ICU时及至第28天连续检测血清铁调素、红细胞生成和炎症指标。中位血清铁调素入ICU时显著升高,随时间下降(144→36 ng/mL,p<0.0001);网织红细胞计数升高(1.3→2.9%),但血清促红细胞生成素水平仍低(29→44 mU/mL),血红蛋白无显著变化。铁调素与红细胞输注、C反应蛋白、白细胞介素-6、铁蛋白正相关,与铁、总铁结合力、转铁蛋白和网织红细胞反应负相关。回归分析证实铁蛋白、C反应蛋白和网织红细胞数是同日铁调素的预测因子,铁调素和C反应蛋白是同日网织红细胞计数的预测因子。

要点

  • 外科成人ICU患者入ICU时中位血清铁调素显著升高(144 ng/mL),至第28天降至36 ng/mL(p<0.0001)。
  • 尽管网织红细胞计数从1.3%升至2.9%,血清促红细胞生成素水平仍低(29→44 mU/mL),血红蛋白无显著变化。
  • 铁调素与红细胞输注、C反应蛋白、白细胞介素-6、铁蛋白正相关,与铁、总铁结合力、转铁蛋白和网织红细胞反应负相关。
  • 铁蛋白、C反应蛋白和网织红细胞数可预测同日铁调素;铁调素和C反应蛋白可预测同日网织红细胞计数。
  • 铁调素下降与网织红细胞反应增加及炎症反应减轻(白细胞介素-6和C反应蛋白下降)相关,但与贫血缓解无关。

适用人群与场景

  • 外科成人ICU患者100例,入ICU时存在贫血。
  • 研究在外科ICU进行,为美国大学医院单中心。

研究设计与关键结果

  • 研究类型:前瞻性单中心临床非干预性研究;样本量100例外科成人ICU患者;无对照组。
  • 主要终点:中位血清铁调素水平在入ICU时显著升高,随时间下降(144→36 ng/mL,p<0.0001)。
  • 关键次要终点:网织红细胞计数从1.3%升至2.9%,平均血清促红细胞生成素水平保持低值(29→44 mU/mL),血红蛋白无显著变化。
  • 相关性:铁调素与红细胞输注、C反应蛋白、白细胞介素-6、铁蛋白正相关,与铁、总铁结合力、转铁蛋白、网织红细胞反应负相关;与肿瘤坏死因子-α无相关性。
  • 回归分析:铁蛋白、C反应蛋白和网织红细胞数是同日铁调素的预测因子;铁调素和C反应蛋白是同日网织红细胞计数的预测因子。

证据类型、等级与局限

  • 证据类型:前瞻性单中心临床非干预性研究(队列研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论提示外科ICU贫血患者铁调素显著升高并随时间下降,铁调素下降与网织红细胞反应增加和炎症反应减轻相关,但与贫血缓解无关;原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Because anemia of inflammation is common in ICU patients and hepcidin is the key regulator of iron homeostasis, we examined time-dependent changes in hepcidin, erythropoietin, iron, and inflammatory markers in surgical ICU patients with anemia.

DESIGN: Prospective single-center clinical noninterventional study.

SETTING: Surgical ICUs; U.S. university hospital.

PATIENTS: One hundred surgical adult ICU patients.

MEASUREMENTS AND MAIN RESULTS: Time-dependent changes in serum hepcidin, hematologic, and erythropoietic studies were performed on ICU admission and at serial time-points through day 28, and correlated with hematologic and iron parameters and inflammatory response. Median serum hepcidin levels were significantly increased at ICU admission and decreased over time (144-36 ng/mL; p < 0.0001). Despite increased reticulocyte counts (1.3-2.9%), mean serum erythropoietin levels remained low (29-44 mU/mL) and hemoglobin did not significantly change. Hepcidin was positively correlated with RBC transfusion, C-reactive protein, interleukin-6, ferritin, and negatively correlated with iron, total iron binding capacity, transferrin, and reticulocyte response. Hepcidin did not correlate with tumor necrosis factor-α serum concentrations. Regression analyses confirmed that ferritin, C-reactive protein, and reticulocyte number were predictive of same-day hepcidin; hepcidin and C-reactive protein were predictive of same-day reticulocyte count.

CONCLUSIONS: Hepcidin serum concentrations are markedly increased on ICU admission, and decrease significantly over the course of the ICU stay (28 d). Decreased hepcidin concentrations are associated with increased reticulocyte response and decreased inflammatory response reflected by decreased interleukin-6 and C-reactive protein concentrations, but not with anemia resolution.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Cherry-Bukowiec JR, Engoren M, Wiktor A, et al. Hepcidin and Anemia in Surgical Critical Care: A Prospective Cohort Study. Crit Care Med. 2018. PMID: 29517550. doi:10.1097/CCM.0000000000003089

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。